Switching from reference adalimumab to biosimilar. Assessment of clinical outcomes in psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Dermatology"
DOI: 10.1111/ijd.16399
Abstract: hypertrichosis in this child. The treatment was stopped, and the patient was switched back to tacrolimus. No treatment was performed on our pediatric patients because safe treatment was a priority over cosmetic needs. Acquired local… read more here.
Keywords: biosimilar assessment; reference adalimumab; hypertrichosis; alopecia areata ... See more keywords